These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 7919566)
1. Tacrine: first drug approved for Alzheimer's disease. Crismon ML Ann Pharmacother; 1994 Jun; 28(6):744-51. PubMed ID: 7919566 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease: how to give and monitor tacrine therapy. Woo JK; Lantz MS Geriatrics; 1995 May; 50(5):50-3. PubMed ID: 7737527 [TBL] [Abstract][Full Text] [Related]
3. Maximizing function in Alzheimer's disease: what role for tacrine? Smucker WD Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842 [TBL] [Abstract][Full Text] [Related]
4. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Wagstaff AJ; McTavish D Drugs Aging; 1994 Jun; 4(6):510-40. PubMed ID: 7521234 [TBL] [Abstract][Full Text] [Related]
9. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. Farlow M; Gracon SI; Hershey LA; Lewis KW; Sadowsky CH; Dolan-Ureno J JAMA; 1992 Nov; 268(18):2523-9. PubMed ID: 1404819 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817 [TBL] [Abstract][Full Text] [Related]
11. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. Knapp MJ; Knopman DS; Solomon PR; Pendlebury WW; Davis CS; Gracon SI JAMA; 1994 Apr; 271(13):985-91. PubMed ID: 8139083 [TBL] [Abstract][Full Text] [Related]
12. Donepezil use in Alzheimer disease. Barner EL; Gray SL Ann Pharmacother; 1998 Jan; 32(1):70-7. PubMed ID: 9475825 [TBL] [Abstract][Full Text] [Related]
13. Methodology, results and quality of clinical trials of tacrine in the treatment of Alzheimer's disease: a systematic review of the literature. Arrieta JL; Artalejo FR Age Ageing; 1998 Mar; 27(2):161-79. PubMed ID: 16296676 [TBL] [Abstract][Full Text] [Related]
14. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine. Chatellier G; Lacomblez L BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926 [TBL] [Abstract][Full Text] [Related]
15. Tacrine therapy for the dementia of Alzheimer's disease. Manning FC Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912 [TBL] [Abstract][Full Text] [Related]
16. Steady-state pharmacokinetics of tacrine in patients with Alzheimer's disease. Cutler NR; Sedman AJ; Prior P; Underwood BA; Selen A; Balogh L; Kinkel AW; Gracon SI; Gamzu ER Psychopharmacol Bull; 1990; 26(2):231-4. PubMed ID: 2236461 [TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease. Samuels SC; Davis KL Drug Saf; 1997 Jan; 16(1):66-77. PubMed ID: 9010644 [TBL] [Abstract][Full Text] [Related]
19. Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease. Allain H; Schück S; Lebreton S; Strenge-Hesse A; Braun W; Gandon JM; Brissot P Dement Geriatr Cogn Disord; 1999; 10(3):181-5. PubMed ID: 10325444 [TBL] [Abstract][Full Text] [Related]
20. Tacrine in Alzheimer's disease: pharmacokinetic and clinical comparison of oral and rectal administration. Ahlin A; Hassan M; Junthé T; Nybäck H Int Clin Psychopharmacol; 1994; 9(4):263-70. PubMed ID: 7868848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]